in 17 prostatic cancer patients , changes in the plasma lipoprotein pattern , including high density lipoprotein ( hdl ) subfractions , and in glucose tolerance were compared after 6 months on parenteral polyestradiol phosphate ( pep ; estradurin , 80 or 160 mg/month ) with the respective changes in orchiectomized patients .
C0071554
polyestradiol phosphate
C0687716
estradurin